Navigation Links
NIH awards OHSU researcher $1.2 million to determine causes of, risk factors for pelvic floor injury
Date:2/26/2008

PORTLAND, Ore. - One of the worlds pre-eminent experts in urogynecology at Oregon Health & Science University has received $1.2 million in grants from the National Institutes of Health to study the extent of pelvic floor injury in women before, during and after pregnancy.

The pelvic floor comprises the muscle group that supports the pelvic organs and maintains bowel continence. Pelvic floor injury, which is caused by damage to pelvic muscles or nerves, can lead to a wide array of disorders, including incontinence and the displacement of organs, also known as organ prolapse.

We hope to be able to determine if some women have inherent characteristics that may make them more susceptible to pelvic floor injury, said W. Thomas Gregory, M.D., F.A.C.O.G., assistant professor of obstetrics and gynecology (urogynecology), OHSU School of Medicine, and member of the OHSU Center for Womens Health. We also hope to be able to conclusively determine whether vaginal birth truly affects pelvic floor strength and coordination; or if there are other factors, such as the pregnancy itself, in play.

In order to map the extent of pelvic floor injury throughout the length of the study, Gregory will use a neurophysiology test frequently used to diagnose injuries or disease outside of the pelvic region, such as carpal tunnel syndrome or amytrophic lateral sclerosis (ALS), commonly known as Lou Gehrigs disease. In this test, a tiny needle inserted into the muscle mass reads the electrical impulses sent by engaged and active muscles; the readings are then examined to determine the function of nerves and muscles in the tested area.

Using this technique to map pelvic floor injury is unusual because it requires training in both neurophysiology and urogynecology, a still nascent subspecialty of obstetrics and gynecology. Gregory is one of the few urogynecologists in the world trained to use this technique.

The need for this kind of research has become increasingly apparent in recent years as a groundswell of health care providers and the public alike have suggested that giving birth via Caesarean section may decrease the risk of sustaining pregnancy-related pelvic floor injuriy. While retrospective studies seem to indicate that this may be the case, this study, to the best of the researchers knowledge, is the first large-scale prospective study to track pelvic floor damage before and after a number of birthing scenarios.

One day we hope to be able to offer women informed choices about preventing pelvic floor disorder - maybe we will find C-sections do reduce the risk of pregnancy-related pelvic floor injuries for some women. Maybe we will find that C-sections do not prevent pelvic floor injury in most women, Gregory said.

Some pelvic floor injury is inevitable throughout a persons lifetime, and disorders resulting from this injury are common among women; recent studies have indicated that one in nine women will at one time undergo surgery to treat the symptoms related to pelvic floor dysfunction.


'/>"/>

Contact: Brycie Jones
jonesbry@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Related medicine news :

1. James Marsden and Ashley & Jeffrey McDermott to Receive Honors at the Tourette Syndrome Association 2008 Champion of Children Awards Dinner
2. Microsoft and Microsoft Healthcare Users Group Announce Winners of MS-HUG Healthcare Innovation Awards 2008
3. Omololu Falobi Awards for Excellence in HIV Prevention Research Community Advocacy presented
4. Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project
5. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
6. AACRs Seventh Annual Landon Awards
7. McGraw-Hill Professional Products Win Awards From Association of American Publishers
8. Eco Site Awards Launched to Honor Organizations Devotion to Ecology, Health, Safety, and the Environment
9. AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards
10. USAID Awards $70 Million for the Prevention and Treatment of Obstetric Fistula
11. Executive Alison Austin and Amadeus North America Receive Deborah Natansohn Awards for Support of Heart Disease Awareness in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology: